Ann: City of Hope Professor Jianjun Chen joins Race's SAB, page-150

An experienced investor in my group posted this:
https://twitter.com/Nucleics_Inc/status/1516507626967736321?t=BlNMungZRiVt8nlHU-jvww&s=07

And said: " Killer T cell killing cancer!.."

Then A New and Young member of my group asked me " What this T cell got to do with RAC..."

Since investing in RAC around when DrT was appointed as a CSO, I have been learning so much from Dr T /Wombat/Mason/ TentCicy/Johndprent/Indexinvestor/Boffin99 and many many more brilliant posters ..I am very grateful and blessed to have such a group of unselfish dedicated people posting and helping everyone unconditionally.

This is what a Finance Broker (I am) trying his best in answering to a New Young investor in RAC that "T cell has a lot to do with RAC particularly Zantrene..". (Pls forgive me if it is too amateur and plain.)

"Killer T CELL killing cancer and T CELL kills cancers better with help from Immu Checkpoint:

PDL1 is the protein are made by cancer cell
PD1 is the protein are made by T cell. (T Cell is a part of immune system. T Cell is like a bodyguard, it helps our body to fight back all infections, including cancer).

When cancer cell creates PDL1 then bind with PD1, this process helps cancer cell to avoid being killed by immune system (T cell).

PD1 inhibitor (immune checkpoint) is a drug that can stop this binding process between PDL1/PD1 and allow T CELL (Immune system) to kill cancer cell. (An Example: Keytruda is number one PD1 inhibitor with an annual revenue of 20 billion usd).

So far COH and we have seen in the lab and Pre clinical results that Immu Checkpoint works better when combined with FTO inhibitor (Zantrene)

In cancer types (29 kinds and counting) that have FTO over expression, PD1 inhibitor become less effective or helpless (FTO over expression causes treatment resistance to PD1 inhibitor).

If we can prove FTO inhibitor (zantrene) helps PD1 inhibitors work better (overcome treatment resistance) in HUMAN , We are in business. FTO inhibitor (Zantrene) will become one of the most important discovery of cancer treatments in this Century.

We are going to have FTO inhibitor proof in HUMAN from Stratum 2 of EMD AML trial sometime this year."
IMO and DYOR.